Latest News

Mankind Pharma receives 'C-' ESG rating from ISS ESG

Source |01:29 05 Jun 25

sustainability press release

Mankind Pharma Limited announced on June 4, 2025, that ISS ESG has voluntarily issued an ESG Corporate Rating Report for the company on June 3, 2025.

The report, based on publicly available data, assigned Mankind Pharma an overall ESG score of 38.98, corresponding to a C- rating.
The company clarified that it has not verified any data on which this rating has been issued.

MANKIND

Mankind Pharma incorporates wholly-owned subsidiary, KINDCARE FOUNDATION

Source |13:29 02 Jun 25

corporate actions regulatory filings

Mankind Pharma Limited has announced the incorporation of a wholly-owned subsidiary (WOS) named KINDCARE FOUNDATION on June 2, 2025.
The subsidiary is incorporated under Section 8 of the Companies Act, 2013.
This announcement follows the company's earlier disclosure on April 14, 2025.

MANKIND

Mankind Pharma to participate in BofA India Conference on June 2, 2025

Source |04:20 27 May 25

corporate actions press release

Mankind Pharma Limited will participate in the BofA India Conference: Changing Growth Contours in Mumbai on June 02, 2025.
The company has informed that no unpublished price sensitive information will be shared at the conference.
The schedule is subject to change due to exigencies.

MANKIND

Mankind Pharma to participate in Investor Conferences in Mumbai

Source |07:34 22 May 25

agm-egm corporate actions

Mankind Pharma Limited will participate in the Nirmal Bang Conference in Mumbai on May 27, 2025.
The company will also participate in the B&K Trinity India 2025 in Mumbai on May 28, 2025.
No unpublished price-sensitive information will be shared at these conferences.
The schedule is subject to change.

MANKIND

Mankind Pharma announces newspaper publication of Q4 and FY25 audited financial results

Source |07:14 22 May 25

results regulatory filings

Mankind Pharma Limited has announced the newspaper publication of its audited financial results for the quarter and financial year ended March 31, 2025.

The extracts of these audited financial results were published in "Financial Express" and "Jansatta" on May 22, 2025.
The complete audited financial results, along with the audit report, are available on the Company's website (www.mankindpharma.com) and on the websites of BSE Limited (www.bseindia.com) and National Stock Exchange of India Limited (www.nseindia.com).
No financial figures or management commentary for Mankind Pharma Limited were provided within this specific announcement content.